Trial Profile
Safety and efficacy of Apatinib combined with chemotherapy in patients with Soft tissue sarcoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jun 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Carboplatin; Cisplatin; Gemcitabine; Ifosfamide; Pirarubicin
- Indications Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- 21 Jun 2018 New trial record
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology